Inhibition of MIF1/MIF2 reduces the tumor burden of bladder cancer in preclinical models, an effect that was found to be accomplished in part through activation of CD74, suggesting the significance of CD74 in tumor development22. Here, CD74 is linked to urinary bladder carcinoma.